Latest filing published 19 Nov 2021 for Flexion Therapeutics Inc, €777k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Melissa Layman: trading record in brief
This profile gathers the share dealings of Melissa Layman in Flexion Therapeutics Inc, where the filings describe the role as senior executive. Over a trading history stretching from 1 April 2020 to 19 November 2021, the count stands at 6 filings.
The open-market record consists of 2 sales worth €72k, with no purchase. Besides market trades, the filings include 3 share grants. In 2021 alone, the filings show no purchases and 2 sales.
On 19 November 2021 came the latest disclosure, a transaction for €777k in Flexion Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Melissa Layman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 103,956 shares@ US$8.50100.0% of flowCommon StockSEC:0001209191-21-065708:0
1 of 1 declaration